UMediC Group Berhad (0256) - Cash Flow Conversion Efficiency
Based on the latest financial reports, UMediC Group Berhad (0256) has a cash flow conversion efficiency ratio of -0.034x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM-2.80 Million ≈ $-702.49K USD) by net assets (RM83.20 Million ≈ $20.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
UMediC Group Berhad - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how UMediC Group Berhad's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 0256 liabilities breakdown for a breakdown of total debt and financial obligations.
UMediC Group Berhad Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of UMediC Group Berhad ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Locksley Resources Ltd
AU:LKY
|
-0.095x |
|
JSW Pacific
TWO:5251
|
-0.049x |
|
Venus Metals Corporation Ltd
AU:VMC
|
-0.014x |
|
A2Z Infra Engineering Limited
NSE:A2ZINFRA
|
-0.172x |
|
RMG Acquisition Corp. III
NASDAQ:RMGCF
|
0.034x |
|
Taya Inv-L
TA:TAYA
|
-0.004x |
|
Barinthus Biotherapeutics plc
NASDAQ:BRNS
|
-0.127x |
|
Goldenstone Acquisition Ltd
NASDAQ:GDST
|
0.061x |
Annual Cash Flow Conversion Efficiency for UMediC Group Berhad (2020–2025)
The table below shows the annual cash flow conversion efficiency of UMediC Group Berhad from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see 0256 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-07-31 | RM81.35 Million ≈ $20.42 Million |
RM11.18 Million ≈ $2.81 Million |
0.137x | +131.41% |
| 2024-07-31 | RM72.77 Million ≈ $18.27 Million |
RM4.32 Million ≈ $1.09 Million |
0.059x | +109.05% |
| 2023-07-31 | RM63.48 Million ≈ $15.94 Million |
RM1.80 Million ≈ $452.94K |
0.028x | -82.34% |
| 2022-07-31 | RM52.68 Million ≈ $13.23 Million |
RM8.48 Million ≈ $2.13 Million |
0.161x | -30.61% |
| 2021-07-31 | RM15.74 Million ≈ $3.95 Million |
RM3.65 Million ≈ $916.46K |
0.232x | +139.33% |
| 2020-07-31 | RM6.63 Million ≈ $1.67 Million |
RM-3.91 Million ≈ $-981.91K |
-0.590x | -- |
About UMediC Group Berhad
UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales s… Read more